Phone
Phone
As an antimicrobial molecule, the active ingredient helps the nasal mucosa prevent colonisation by airborne pathogenic bacteria. The already existing antimicrobial environment of the nasal mucosa is additionally enhanced by Hexedra+.
In this way, higher bacterial loads can be eliminated from the nasal mucosa without them entering the bloodstream from the nasal mucosa.
In addition, the natural molecule covers/envelopes the existing cells in the nasal mucosa and masks the receptors (ACE3/ TMPRSS2) on the surface. Through this masking, the virus is not able to access the receptor and penetrate the cell.
Therefore, the virus cannot infect the cell and the defence mechanisms of the nasal mucosa can eliminate the exposed virus. Even higher loads of viruses can be eliminated by the defence forces of the nasal mucosa over time, without the viruses affecting a cell. This results in an active mechanical barrier against pathogenic microbes.
Hexedra+ is a nasal spray based on an active natural ingredient patented (PCT) that offers an effective protection against visus and bacteria transmitted through the nasal mucosa.
Vestatis GmbH is focused on the research, development and marketing of innovative substances which can protect the health and safety of people and facilities.